Skip to main content
Premium Trial:

Request an Annual Quote

ABI Releases TaqMan Assay Data to Public Database

NEW YORK (GenomeWeb News) - Applied Biosystems has released into the public domain the validation data for its TaqMan drug metabolism genotyping assays, the company said today.
The data, which was released through the Pharmacogenomics Knowledge Base, is aimed at helping researchers understand how genetic variation among individuals contributes to differences in reactions to drugs.
Researchers can use the data on validated genotyping assays available in PharmGKB to “expedite the design and execution of genetic studies correlating genotype to drug efficacy or toxicity,” said Teri Klein, director of the PharmGKB project at Stanford University.
Applied Biosystems also said studies show that its TaqMan assays provide higher accuracy than other methodologies in identifying variations in genes that code for drug metabolism enzymes.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.